- Home
- QNCX vs LEE Comparison
QNCX vs LEE Comparison
Compare QNCX & LEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QNCX
- LEE
- Stock Information
- Founded
- QNCX 2012
- LEE 1890
- Country
- QNCX United States
- LEE United States
- Employees
- QNCX N/A
- LEE N/A
- Industry
- QNCX Biotechnology: Biological Products (No Diagnostic Substances)
- LEE Newspapers/Magazines
- Sector
- QNCX Health Care
- LEE Consumer Discretionary
- Exchange
- QNCX Nasdaq
- LEE Nasdaq
- Market Cap
- QNCX 85.9M
- LEE 42.1M
- IPO Year
- QNCX 2019
- LEE N/A
- Fundamental
- Price
- QNCX $1.61
- LEE $5.23
- Analyst Decision
- QNCX Strong Buy
- LEE
- Analyst Count
- QNCX 6
- LEE 0
- Target Price
- QNCX $8.00
- LEE N/A
- AVG Volume (30 Days)
- QNCX 137.7K
- LEE 50.5K
- Earning Date
- QNCX 11-12-2025
- LEE 08-07-2025
- Dividend Yield
- QNCX N/A
- LEE N/A
- EPS Growth
- QNCX N/A
- LEE N/A
- EPS
- QNCX N/A
- LEE N/A
- Revenue
- QNCX N/A
- LEE $581,809,000.00
- Revenue This Year
- QNCX N/A
- LEE N/A
- Revenue Next Year
- QNCX N/A
- LEE N/A
- P/E Ratio
- QNCX N/A
- LEE N/A
- Revenue Growth
- QNCX N/A
- LEE N/A
- 52 Week Low
- QNCX $0.69
- LEE $3.79
- 52 Week High
- QNCX $2.45
- LEE $19.63
- Technical
- Relative Strength Index (RSI)
- QNCX 49.14
- LEE 58.64
- Support Level
- QNCX $1.56
- LEE $4.26
- Resistance Level
- QNCX $1.67
- LEE $6.95
- Average True Range (ATR)
- QNCX 0.07
- LEE 0.49
- MACD
- QNCX 0.00
- LEE 0.20
- Stochastic Oscillator
- QNCX 69.70
- LEE 45.05
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
About LEE Lee Enterprises Incorporated
Lee Enterprises Inc is a local news publication company in the United States. It is a digital-first subscription business providing local markets with valuable, high-quality, trusted, intensely local news, information, advertising, and marketing services. The product portfolio of the company includes digital subscription platforms, daily, weekly, and monthly newspapers, and niche products, all delivering original local news and information as well as national and international news. The products offer digital and print editions, and content and advertising are available in real-time through the websites and mobile apps.